Contracting Officer, Code 074, Naval Hospital, Boone Road, Bremerton, WA 98312-1898

65 -- RADIOPHARMACEUTICAL STANDING ORDER SOL N68095-98-Q-1014 DUE 091897 POC Becky Smith, Purchasing Agent, 360-478-9462 The Naval Hospital, Bremerton WA requires a STANDING/DELIVERY ORDER FOR RADIOPHARMACEUTICALS. Contract period is from 10-1-97 to 09-30-98. Required items are as follows: (ESTIMATED) Schillings Dicipac -- 5EA/YR; Gallium-67 Citrate -- 30EA/yr; Tc99m Sestamibi (Compounding Fee) -- 268EA/YR; Tc99m Mebrofenin -- 40EA/YT; Tc99m MAA -- 20EA/YR; Tc99m DTPA AEROSOL - 20EA/YR; Tc99m Mertiatide -- 32EA/YR; Tc99m MDP -- 425EA/YR; Tc99m ALBUMIN COLLOID -- 27EA?YR; Tc99m Glucoheptate 1EA/YR; Tc99m DMSA -- 1EA/YR; 99mTc04 Multidose (50mCi) -- 365EA/YR; Tc99mHMPAO-WBC -- 7 EA/YR; Indinum 111 WBC -- 11EA/YR; I-131 NAI Therapy Capsule (15mCi) -- 5EA/YR; I-123 100uCi Capsule -- 21EA/YR; I-123 200uCi Capsule -- 21EA/YR; TI-201 (1mCi) -- 20EA/YR. DELIVERY AND RESPONSE REQUIREMENTS: 1) Delivery of routine Radiopharmaceuticals orders will be delivered no later than 0730 on required date. 2) Emergency orders placed during normal working hours will be delivered within 1 hour of order placement. 3) After normal working hours/weekends all emergency orders placed will be delivered within 2 hours of order placement. 4) Products delivered that do not meet delivery schedule requirements will be billed at 50% of contract rate. 5) WBC Labeling must be completed and returned to Naval Hospital within 5 hours of taking custody of the patient's whole blood. RADIOPHARMACEUTICAL REQUIREMENTS: 1) Radio-Purity testing will be performed on all (exception- WBC Labeling) products delivered to Naval Hospital. All products must meet the Kit Manufacturer's minimum Radio-Purity requirement. 2) No product substitutions will be allowed without prior approval of a nuclear medicine technologist. 3) TC MAA doses will not exceed the product insert maximum suggested number of particles. In cases when the pharmacy is notified that the dose is for a patient with Pulmonary Hypertension or a right shunt no more than 100,000 particles will be provided. 4) All diagnostic Radiopharmaceuticals must be within +-10% of the dose calibrated for the estimated time of use. 5) All I-131 NAI Therapeutical capsules must be within +-5% of the dose requested. These products will be calibrated for the estimated time of use. 6) M099 breakthrough concentration will never exceed 0.15 uCi/mCi Tc99m. 7) Aluminum levels will always be 10ugm/ml. 8) Cardiolite vial partitioning is allowed. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Far 52.212-1 Instructions to Offerors -- Commercial; Far 52.212-2 Evaluation - Commercial Items; Far 52.212-3 Offeror Representation and Certifications - Commercial Items; Far 52.212-4 Contract Terms and Conditions -- Commercial Items; Far 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Excutive Orders -- Commercial Items. Award is to be made under Simplified Acquisition Procedures. All responsible sources may submit a quotation by fax to 36-478-946***** (0251)

Loren Data Corp. http://www.ld.com (SYN# 0294 19970911\65-0004.SOL)